RAGE and cardiovascular disease

Sungha Park, Se Jung Yoon, Hyun Jin Tae, Chi Young Shim

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

RAGE is pattern recognizing receptors for diverse endogenous ligands. RAGE activation by RAGE ligands is known to be associated with reactive oxygen species generation, activation of NF kappa B, as well as recruitment of proinflammatory cells. Activated endothelial cells, vascular smooth muscle cells in atherosclerotic plaques and activated inflammatory cells all have increased expression of RAGE, which with its interaction with RAGE ligands increases the secretion of proinflammatory cytokines and cell adhesion molecules. Furthermore, RAGE may have a significant role in leukocyte recruitment into the intima of the atherosclerosis. Initial insults resulting in endothelial dysfunction will result in leukocyte infiltration, oxidative stress and vascular inflammation that is amplified by RAGE activation. RAGE and its interaction with RAGE ligands may be important for initializing and maintaining the pathological processes that result in various entities of cardiovascular disease. Soluble RAGE competitively inhibits the binding of RAGE ligands to RAGE and attenuates the development of atherosclerosis in vivo. Thus RAGE may be a promising target for treatment of cardiovascular disease in the future.

Original languageEnglish
Pages (from-to)486-497
Number of pages12
JournalFrontiers in Bioscience
Volume16
Issue number2
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Cardiovascular Diseases
Ligands
Chemical activation
Atherosclerosis
Leukocytes
Oxidative stress
NF-kappa B
Endothelial cells
Cell Adhesion Molecules
Atherosclerotic Plaques
Pathologic Processes
Vascular Smooth Muscle
Infiltration
Smooth Muscle Myocytes
Blood Vessels
Muscle
Reactive Oxygen Species
Oxidative Stress
Endothelial Cells
Cells

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Park, Sungha ; Yoon, Se Jung ; Tae, Hyun Jin ; Shim, Chi Young. / RAGE and cardiovascular disease. In: Frontiers in Bioscience. 2011 ; Vol. 16, No. 2. pp. 486-497.
@article{18f5c853e8254e7b8e8fd51182cf2e9a,
title = "RAGE and cardiovascular disease",
abstract = "RAGE is pattern recognizing receptors for diverse endogenous ligands. RAGE activation by RAGE ligands is known to be associated with reactive oxygen species generation, activation of NF kappa B, as well as recruitment of proinflammatory cells. Activated endothelial cells, vascular smooth muscle cells in atherosclerotic plaques and activated inflammatory cells all have increased expression of RAGE, which with its interaction with RAGE ligands increases the secretion of proinflammatory cytokines and cell adhesion molecules. Furthermore, RAGE may have a significant role in leukocyte recruitment into the intima of the atherosclerosis. Initial insults resulting in endothelial dysfunction will result in leukocyte infiltration, oxidative stress and vascular inflammation that is amplified by RAGE activation. RAGE and its interaction with RAGE ligands may be important for initializing and maintaining the pathological processes that result in various entities of cardiovascular disease. Soluble RAGE competitively inhibits the binding of RAGE ligands to RAGE and attenuates the development of atherosclerosis in vivo. Thus RAGE may be a promising target for treatment of cardiovascular disease in the future.",
author = "Sungha Park and Yoon, {Se Jung} and Tae, {Hyun Jin} and Shim, {Chi Young}",
year = "2011",
month = "1",
day = "1",
doi = "10.2741/3700",
language = "English",
volume = "16",
pages = "486--497",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "2",

}

RAGE and cardiovascular disease. / Park, Sungha; Yoon, Se Jung; Tae, Hyun Jin; Shim, Chi Young.

In: Frontiers in Bioscience, Vol. 16, No. 2, 01.01.2011, p. 486-497.

Research output: Contribution to journalArticle

TY - JOUR

T1 - RAGE and cardiovascular disease

AU - Park, Sungha

AU - Yoon, Se Jung

AU - Tae, Hyun Jin

AU - Shim, Chi Young

PY - 2011/1/1

Y1 - 2011/1/1

N2 - RAGE is pattern recognizing receptors for diverse endogenous ligands. RAGE activation by RAGE ligands is known to be associated with reactive oxygen species generation, activation of NF kappa B, as well as recruitment of proinflammatory cells. Activated endothelial cells, vascular smooth muscle cells in atherosclerotic plaques and activated inflammatory cells all have increased expression of RAGE, which with its interaction with RAGE ligands increases the secretion of proinflammatory cytokines and cell adhesion molecules. Furthermore, RAGE may have a significant role in leukocyte recruitment into the intima of the atherosclerosis. Initial insults resulting in endothelial dysfunction will result in leukocyte infiltration, oxidative stress and vascular inflammation that is amplified by RAGE activation. RAGE and its interaction with RAGE ligands may be important for initializing and maintaining the pathological processes that result in various entities of cardiovascular disease. Soluble RAGE competitively inhibits the binding of RAGE ligands to RAGE and attenuates the development of atherosclerosis in vivo. Thus RAGE may be a promising target for treatment of cardiovascular disease in the future.

AB - RAGE is pattern recognizing receptors for diverse endogenous ligands. RAGE activation by RAGE ligands is known to be associated with reactive oxygen species generation, activation of NF kappa B, as well as recruitment of proinflammatory cells. Activated endothelial cells, vascular smooth muscle cells in atherosclerotic plaques and activated inflammatory cells all have increased expression of RAGE, which with its interaction with RAGE ligands increases the secretion of proinflammatory cytokines and cell adhesion molecules. Furthermore, RAGE may have a significant role in leukocyte recruitment into the intima of the atherosclerosis. Initial insults resulting in endothelial dysfunction will result in leukocyte infiltration, oxidative stress and vascular inflammation that is amplified by RAGE activation. RAGE and its interaction with RAGE ligands may be important for initializing and maintaining the pathological processes that result in various entities of cardiovascular disease. Soluble RAGE competitively inhibits the binding of RAGE ligands to RAGE and attenuates the development of atherosclerosis in vivo. Thus RAGE may be a promising target for treatment of cardiovascular disease in the future.

UR - http://www.scopus.com/inward/record.url?scp=79955029506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955029506&partnerID=8YFLogxK

U2 - 10.2741/3700

DO - 10.2741/3700

M3 - Article

C2 - 21196183

AN - SCOPUS:79955029506

VL - 16

SP - 486

EP - 497

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 2

ER -